Japan residents to get free COVID-19 vaccine

covid
Credit: Pixabay/CC0 Public Domain

Japan will give free coronavirus vaccines to all of its residents under a bill passed Wednesday, as the nation battles record numbers of daily cases.

The bill, which says the government will cover all costs for Japan's 126 million residents, was approved by the upper house of parliament, having cleared the powerful lower house.

The country has secured COVID-19 vaccines for 60 million people from pharmaceutical giant Pfizer, and for a further 25 million people from biotech firm Moderna.

It has also confirmed it will receive 120 million doses of AstraZeneca's vaccine.

Pfizer and Moderna are already seeking emergency-use approval in the United States and Europe, after clinical tests showed their jabs were effective.

The bill's passage comes two weeks after Japan's said the country was on "maximum alert" over the virus, and as medics warn hospitals are on the brink of collapse.

Japan has seen a comparatively small COVID-19 outbreak overall, with around 2,100 deaths and 150,000 cases, and has not imposed the strict lockdowns seen elsewhere.

But it is now facing a third wave of the disease, reporting record numbers of daily infections nationwide in recent weeks.

Tokyo's governor has urged residents to avoid non-essential outings and asked businesses serving alcohol to shut early, although there is no enforcement mechanism for these recommendations.

The has also decided to allow individual regions to opt out of a controversial domestic tourism campaign.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2020 AFP

Citation: Japan residents to get free COVID-19 vaccine (2020, December 2) retrieved 24 January 2021 from https://medicalxpress.com/news/2020-12-japan-residents-free-covid-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments